サマリー

睡眠時無呼吸症候群治療器の世界市場は、2023年の58億米ドルから2028年には80億米ドルに達すると予測され、予測期間中の年平均成長率は6.5%に達するとされています。この市場の成長は、睡眠時無呼吸症候群の機器や治療法に対する償還の増加が主な要因となっています。しかし、CPAPのコストが高いため、睡眠時無呼吸症候群のデバイス市場の成長は抑制されます。
"睡眠時無呼吸症候群PAPデバイスシステム市場において、予測期間中、タイプ別ではCPAPデバイスセグメントが最も高い市場シェアを占めた"
睡眠時無呼吸症候群PAPデバイスシステム市場は、タイプ別セグメントに基づき、持続気道陽圧（CPAP）デバイス、自動気道陽圧（APAP）デバイス、バイレベル気道陽圧（BPAP）デバイスに分類される。持続気道陽圧（CPAP）デバイスは、気道を開くために連続的かつ一定の陽圧を供給します。CPAPはゴールドスタンダードと呼ばれ、最も一般的に使用されているPAP装置です。

「予測期間中、最も高いCAGRを占めたのは家庭用睡眠検査装置システムです。
タイプに基づき、診断用睡眠時無呼吸装置システンス市場は、睡眠ポリグラフ装置、家庭用睡眠検査装置、オキシメーター、アクチグラフシステム、睡眠スクリーニング装置に区分されます。2022年は、ポリソムノグラフィデバイスシステムが市場を支配し、ホームスリープテストデバイスシステムが最も高い成長率を観察することになります。在宅睡眠検査装置の成長を支える要因は、在宅患者、高齢者、または在宅で専門的なケアを必要とする慢性疾患患者に対する優位性によるものである。

"予測期間中の地域別睡眠時無呼吸装置システム市場では、アジア太平洋地域が最も高い成長率を占めた"
地域別に見ると、世界の睡眠時無呼吸症候群デバイス市場は、北米、欧州、アジア太平洋地域、その他の地域に分類されます。アジア太平洋地域は、予測期間中に高い成長率を示すと予想されています。膨大な患者数と未診断の患者数が、アジア太平洋地域の睡眠時無呼吸症候群の市場に大きな可能性をもたらしています。
供給側の一次インタビューの内訳、企業タイプ別、呼称別、地域別：
- 企業タイプ別ティア1（55％）、ティア2（40％）、ティア3（5％）。
- 役職別Cレベル(37%)、ディレクターレベル(48%)、その他(15%)
- 地域別北米（56％）、アジア太平洋（20％）、ヨーロッパ（17％）、その他の地域（7％）。
主な企業は、ResMed（米国）、Koninklijke Philips N.V.（オランダ）、Fisher & Paykel Healthcare（ニュージーランド）、Inspire Medical Systems, Inc（米国）、SomnoMed（オーストラリア）、Oventus Medical（オーストラリア）、Compumedics（オーストラリア）、Löwenstein Medical Technology GmbH + Co.K.G.（ドイツ）、Drive DeVilbiss Healthcare（米国）、BMC Medical Co.（中国）、BRAEBON Medical Corporation（カナダ）、Whole You、Inc.(米国）、Panthera Dental（カナダ）、Myerson LLC（米国）、ProSomnus Sleep Technologies（米国）、Nidek Medical India（インド）、Toned GmbH（ドイツ）、LivaNova（英国）、Invacare Corporation（米国）、MPowrx Health & Wellness（カナダ）、日本光電（日本）、Natus Medical Incorporated（米国）、Vivos Therapeutics，Inc（米国）、エアウェイマネジメント（米国）、アプネア・サイエンスをご紹介しました。

調査対象
この調査レポートは、睡眠時無呼吸症候群デバイス市場を製品別（治療用デバイス、診断用デバイス）、エンドユーザー別（睡眠研究所、クリニック＆病院、在宅ケア環境／個人）、地域別（北米、欧州、アジア太平洋、その他の地域）に分類しています。本レポートの範囲は、睡眠時無呼吸症候群デバイス市場の成長に影響を与える推進要因、阻害要因、課題、機会などの主要要因に関する詳細情報をカバーしています。主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、協定、新製品・サービスの発売、M&A、睡眠時無呼吸装置市場に関連する最近の動向に関する洞察を提供しています。睡眠時無呼吸症候群のデバイス市場のエコシステムにおける今後の新興企業の競争力分析もカバーしています。

レポートを購入する主な利点
本レポートは、睡眠時無呼吸症候群のデバイス市場全体とサブセグメントの収益数の最も近い近似値に関する情報で、この市場の市場リーダー/新規参入者を支援します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。
本レポートは、以下のポイントに関する洞察を提供します：
- 主要な推進要因の分析（未診断の睡眠時無呼吸症候群患者の大規模なプール、睡眠時無呼吸症候群のデバイスと治療に対する有利な償還と財政援助、未治療の睡眠時無呼吸症候群の影響に対する意識の高まり、口腔器具の使用の増加、睡眠時無呼吸症候群デバイスと口腔器具市場に参入する企業数の増加）、睡眠時無呼吸症候群デバイス市場の成長に影響を与える阻害要因（CPAPマシンの高コスト、複雑な紹介経路と長い待機期間、代替療法と薬）、機会（在宅睡眠時無呼吸検査への需要の高まり、遠隔医療、mHealth、AIへの注目の高まり、新興市場）、課題（CPAPに伴うコンプライアンスの悪さ
- 製品開発/イノベーション：睡眠時無呼吸症候群治療器市場における今後の技術、研究開発活動、新製品・サービス開始に関する詳細なインサイトを掲載。
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域の睡眠時無呼吸症候群装置市場を分析しています。
- 市場の多様化：睡眠時無呼吸症候群の新製品・サービス、未開拓の地域、最近の開発、投資などに関する詳細な情報
- 競争力のある評価：ResMed社（米国）、Koninklijke Philips N.V.（オランダ）、Fisher & Paykel Healthcare社（ニュージーランド）など、睡眠時無呼吸装置市場戦略における主要企業の市場シェア、成長戦略、サービス提供状況を詳細に評価します。

ページTOPに戻る

目次

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
TABLE 1 INCLUSIONS AND EXCLUSIONS 39
1.3 STUDY SCOPE 40
FIGURE 1 SLEEP APNEA DEVICES MARKET SCOPE 40
1.3.1 YEARS CONSIDERED 41
1.4 CURRENCY CONSIDERED 41
1.5 STAKEHOLDERS 41
1.6 SUMMARY OF CHANGES 42
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
FIGURE 2 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN METHODOLOGY 43
2.1.1 SECONDARY DATA 44
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 46
FIGURE 3 PRIMARY SOURCES 46
2.1.2.1 Key industry insights 47
2.1.2.2 Key data from primary sources 47
2.1.2.3 Breakdown of primary interviews 48
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 48
2.2 MARKET SIZE ESTIMATION 48
2.2.1 BOTTOM-UP APPROACH 49
2.2.1.1 Approach 1: Company revenue estimation approach 49
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 49
2.2.1.2 Approach 2: Presentations of companies and primary interviews 49
2.2.1.3 Approach 3: Patient-based approach 50
FIGURE 6 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS 50
2.2.2 GROWTH FORECAST 51
2.2.3 CAGR PROJECTIONS 51
FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 51
2.2.4 TOP-DOWN APPROACH 51
FIGURE 8 SLEEP APNEA DEVICES MARKET: TOP-DOWN APPROACH 52
2.3 DATA TRIANGULATION 52
FIGURE 9 DATA TRIANGULATION METHODOLOGY 53
2.4 STUDY ASSUMPTIONS 54
2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 54
TABLE 2 RISK ASSESSMENT: SLEEP APNEA DEVICES MARKET 55
3 EXECUTIVE SUMMARY 56
FIGURE 10 SLEEP APNEA DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 56
FIGURE 11 SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 57
FIGURE 12 SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 57
FIGURE 13 SLEEP APNEA DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 58
FIGURE 14 SLEEP APNEA DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 59
4 PREMIUM INSIGHTS 60
4.1 SLEEP APNEA DEVICES MARKET OVERVIEW 60
FIGURE 15 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS GLOBALLY TO DRIVE MARKET 60
4.2 SLEEP APNEA DEVICES MARKET, BY REGION (2023–2028) 61
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 61
4.3 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT AND COUNTRY (2022) 61
FIGURE 17 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SLEEP APNEA DEVICES MARKET IN 2022 61
4.4 SLEEP APNEA DEVICES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 62
FIGURE 18 ASIA PACIFIC TO GROW AT HIGHEST RATE DURING STUDY PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 19 SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
5.2.1 DRIVERS 64
5.2.1.1 Large pool of undiagnosed sleep apnea patients globally 64
TABLE 3 PREVALENCE OF SLEEP APNEA IN 2020 64
5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies 65
TABLE 4 REIMBURSEMENT CODES AND COSTS OF MAJOR SLEEP APNEA DEVICES BY RESMED 66
TABLE 5 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL 67
5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients 67
TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA 67
5.2.1.4 Growing usage of oral appliances among patients with mild to low-moderate sleep apnea 68
TABLE 7 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA 68
5.2.1.5 Rising number of companies in sleep apnea devices and oral appliances market 69
5.2.2 RESTRAINTS 69
5.2.2.1 High cost of CPAP machines and minimal insurance access in developing countries 69
5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis 70
5.2.2.3 Alternative therapies and medications for sleep apnea 70
5.2.3 OPPORTUNITIES 71
5.2.3.1 Growing demand for home sleep apnea tests as cost-saving measure 71
5.2.3.2 Increasing focus on telemedicine, mHealth, and AI 72
5.2.3.3 Increased interest of sleep apnea device manufacturers toward emerging markets 72
5.2.4 CHALLENGES 73
5.2.4.1 Poor patient compliance associated with CPAP therapy 73
5.3 PRICING ANALYSIS 74
TABLE 8 AVERAGE SELLING PRICE OF PAP DEVICES 74
TABLE 9 AVERAGE SELLING PRICE OF FACIAL INTERFACES 74
TABLE 10 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL APPLIANCES 75
TABLE 11 COST OF SLEEP APNEA TESTING METHODS 75
TABLE 12 AVERAGE SELLING PRICE OF SLEEP APNEA DEVICES, BY KEY PLAYER 76
5.4 VALUE CHAIN ANALYSIS 76
FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 76
5.5 SUPPLY CHAIN ANALYSIS 77
FIGURE 21 DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY OF PROMINENT COMPANIES 78
5.6 PORTER’S FIVE FORCES ANALYSIS 78
5.6.1 THREAT OF NEW ENTRANTS 78
5.6.2 THREAT OF SUBSTITUTES 79
5.6.3 BARGAINING POWER OF SUPPLIERS 79
5.6.4 BARGAINING POWER OF BUYERS 79
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 79
5.7 ECOSYSTEM ANALYSIS 80
FIGURE 22 SLEEP APNEA DEVICES MARKET: ECOSYSTEM ANALYSIS 80
5.7.1 ROLE IN ECOSYSTEM 80
FIGURE 23 KEY PLAYERS IN SLEEP APNEA DEVICES MARKET ECOSYSTEM 81
5.8 REGULATORY ANALYSIS 81
TABLE 13 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING SLEEP APNEA DEVICES 81
5.8.1 NORTH AMERICA 82
5.8.1.1 US 82
TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 82
5.8.1.1.1 Reimbursement scenario in US 83
5.8.1.2 Canada 83
TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 83
5.8.2 EUROPE 84
5.8.3 ASIA PACIFIC 84
5.8.3.1 Japan 84
TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 84
5.8.3.2 China 85
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 85
5.8.3.3 India 86
5.8.3.4 Australia 86
5.9 PATENT ANALYSIS 87
5.9.1 PATENT TRENDS FOR SLEEP APNEA DEVICES 87
FIGURE 24 PATENT TRENDS FOR SLEEP APNEA DEVICES, JANUARY 2012–DECEMBER 2022 87
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 88
FIGURE 25 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR SLEEP APNEA ORAL APPLIANCE PATENTS, JANUARY 2012–DECEMBER 2022 88
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 89
5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS 89
FIGURE 26 REVENUE SHIFT FOR SLEEP APNEA DEVICES 89
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 90
TABLE 18 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022–2023 90
5.12 TECHNOLOGY ANALYSIS 91
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 92
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 92
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES 92
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES (%) 92
5.13.2 BUYING CRITERIA 92
FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES 92
TABLE 20 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES 93
5.14 TRADE ANALYSIS 93
5.14.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018–2022 (USD MILLION) 93
5.14.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018–2022 (USD MILLION) 94
 
6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA 95
6.1 INTRODUCTION 95
6.2 EPIDEMIOLOGICAL ASSESSMENT 95
FIGURE 29 TOP TEN COUNTRIES WITH HIGHEST OBSTRUCTIVE SLEEP APNEA PATIENTS (BASED ON AMERICAN ACADEMY OF SLEEP MEDICINE, 2012) 96
6.3 PRESCRIPTION PATTERN ASSESSMENT 97
6.4 ADHERENCE ASSESSMENT 98
7 ALTERNATE THERAPIES FOR SLEEP APNEA 100
7.1 INTRODUCTION 100
7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE 100
7.3 HYPOGLOSSAL NERVE STIMULATION 100
7.4 ORAL PRESSURE THERAPY 101
7.5 POSITIONAL THERAPY 101
8 SLEEP APNEA DEVICES MARKET, BY TYPE 103
8.1 INTRODUCTION 104
TABLE 21 SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
8.2 THERAPEUTIC DEVICES 104
TABLE 22 SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 105
TABLE 23 SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY REGION, 2021–2028 (USD MILLION) 105
8.2.1 PAP DEVICES 105
TABLE 24 PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 25 PAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 106
8.2.1.1 CPAP devices 106
8.2.1.1.1 CPAP devices to provide best standard sleep apnea treatment for patients globally 106
TABLE 26 CPAP DEVICES OFFERED BY KEY PLAYERS 107
TABLE 27 CPAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 108
8.2.1.2 APAP devices 109
8.2.1.2.1 Increasing patient non-compliance with CPAP devices and growing awareness among sleep specialists to boost segment 109
TABLE 28 APAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 109
8.2.1.3 BPAP devices 110
8.2.1.3.1 Increased complexity and cost with high product recalls from major companies to lower adoption 110
TABLE 29 BPAP DEVICES OFFERED BY KEY PLAYERS 110
TABLE 30 BPAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 111
8.2.2 FACIAL INTERFACES 111
TABLE 31 FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 32 FACIAL INTERFACES MARKET, BY REGION, 2021–2028 (USD MILLION) 112
8.2.2.1 Masks 112
TABLE 33 MASKS OFFERED BY KEY PLAYERS 113
TABLE 34 MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 35 MASKS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
8.2.2.1.1 Full-face masks 115
8.2.2.1.1.1 Full-face masks to be most effective for mouth breathers or patients struggling with breathing through nose 115
TABLE 36 FULL-FACE MASKS OFFERED BY KEY PLAYERS 115
TABLE 37 FULL-FACE MASKS MARKET, BY REGION, 2021–2028 (USD MILLION) 116
8.2.2.1.2 Nasal pillow masks 116
8.2.2.1.2.1 Greater patient compliance due to smaller size and better fit to drive demand 116
TABLE 38 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS 116
TABLE 39 NASAL PILLOW MASKS MARKET, BY REGION, 2021–2028 (USD MILLION) 117
8.2.2.1.3 Nasal masks 117
8.2.2.1.3.1 Nasal masks to minimize obstruction of patients’ view and allow patients to wear spectacles 117
TABLE 40 NASAL MASKS MARKET, BY REGION, 2021–2028 (USD MILLION) 118
8.2.2.2 Cushions 118
8.2.2.2.1 Different product varieties and launches by major companies in past few years to drive market 118
TABLE 41 CUSHIONS OFFERED BY KEY PLAYERS 118
TABLE 42 CUSHIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
8.2.3 ACCESSORIES 119
TABLE 43 ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 44 ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 120
8.2.3.1 Humidifier accessories 120
8.2.3.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing 120
TABLE 45 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 120
8.2.3.2 Power accessories 121
8.2.3.2.1 Power accessories to manage uninterrupted sleep apnea therapy in absence of power supply 121
TABLE 46 POWER ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 121
8.2.3.3 Transportation accessories 121
8.2.3.3.1 Convenience associated with transportation accessories while traveling to drive market 121
TABLE 47 TRANSPORTATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 122
8.2.3.4 Communication accessories 122
8.2.3.4.1 Communication accessories to monitor sleep apnea symptoms through teleconsultations 122
TABLE 48 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 122
 
8.2.3.5 Chin restraints 123
8.2.3.5.1 Chin restraints to hold mouth in position during therapy 123
TABLE 49 CHIN RESTRAINTS MARKET, BY REGION, 2021–2028 (USD MILLION) 123
8.2.3.6 Other accessories 123
TABLE 50 OTHER ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 124
8.2.4 ORAL APPLIANCES 124
TABLE 51 ORAL APPLIANCES OFFERED BY KEY PLAYERS 125
TABLE 52 ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 53 ORAL APPLIANCES MARKET, BY REGION, 2021–2028 (USD MILLION) 126
8.2.4.1 Mandibular advancement devices 126
8.2.4.1.1 Mandibular advancement devices to treat mild obstructive sleep apnea and snoring 126
TABLE 54 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 127
8.2.4.2 Tongue-retaining devices 127
8.2.4.2.1 Tongue-retaining devices to be less expensive and reduce both snoring and sleep apnea 127
TABLE 55 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 127
8.2.5 ADAPTIVE SERVO-VENTILATORS 128
8.2.5.1 Improved clinical outcomes associated and better ventilation support as per breathing patterns to fuel market 128
TABLE 56 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 128
8.2.6 OTHER THERAPEUTIC DEVICES 129
TABLE 57 OTHER THERAPEUTIC DEVICES OFFERED BY KEY PLAYERS 129
TABLE 58 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 130
8.3 DIAGNOSTIC DEVICES 130
TABLE 59 SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 60 SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY REGION, 2021–2028 (USD MILLION) 131
8.3.1 PSG DEVICES 131
TABLE 61 PSG DEVICES OFFERED BY KEY PLAYERS 131
TABLE 62 PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 63 PSG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 132
8.3.1.1 Ambulatory PSG devices 132
8.3.1.1.1 Cost-effectiveness and convenience for patients to propel segment 132
TABLE 64 AMBULATORY PSG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 133
8.3.1.2 Clinical PSG devices 133
8.3.1.2.1 Requirement of constant supervision to limit segment growth 133
TABLE 65 CLINICAL PSG DEVICES OFFERED BY KEY PLAYERS 133
TABLE 66 CLINICAL PSG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 134
8.3.2 HOME SLEEP TESTING DEVICES 134
8.3.2.1 Cost-effectiveness and comfort of home sleep testing to augment segment 134
TABLE 67 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 135
8.3.3 OXIMETERS 135
TABLE 68 OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 69 OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
8.3.3.1 Fingertip oximeters 136
8.3.3.1.1 Lack of precise readings because of injury or slow blood flow due to blood clotting to limit segment 136
TABLE 70 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS 136
TABLE 71 FINGERTIP OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 137
8.3.3.2 Handheld oximeters 137
8.3.3.2.1 Handheld oximeters to be more expensive than fingertips and wrist-worn oximeters 137
TABLE 72 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS 137
TABLE 73 HANDHELD OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
8.3.3.3 Wrist-worn oximeters 138
8.3.3.3.1 Small size, long-term usage, and need for overnight monitoring to propel segment 138
TABLE 74 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS 138
TABLE 75 WRIST-WORN OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 139
8.3.3.4 Tabletop oximeters 139
8.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share 139
TABLE 76 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS 139
TABLE 77 TABLETOP OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 140
8.3.4 ACTIGRAPHY SYSTEMS 140
8.3.4.1 Increased focus on assessing actimeter performance to enhance market 140
TABLE 78 ACTIGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 141
8.3.5 SLEEP SCREENING DEVICES 141
8.3.5.1 Increasing preference for home-based testing for its efficacy and comfort to drive market 141
TABLE 79 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS 141
TABLE 80 SLEEP SCREENING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 142
 
9 SLEEP APNEA DEVICES MARKET, BY END USER 143
9.1 INTRODUCTION 144
TABLE 81 SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 144
9.2 SLEEP LABORATORIES, CLINICS, AND HOSPITALS 144
9.2.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 144
TABLE 82 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES, CLINICS, AND HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 146
9.3 HOME CARE SETTINGS/INDIVIDUALS 146
9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET 146
TABLE 83 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2021–2028 (USD MILLION) 147
10 SLEEP APNEA DEVICES MARKET, BY REGION 148
10.1 INTRODUCTION 149
TABLE 84 SLEEP APNEA DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 149
10.2 NORTH AMERICA 149
10.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 149
FIGURE 30 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT 150
TABLE 85 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 86 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 87 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 88 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 89 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 90 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 91 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 92 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 93 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 94 NORTH AMERICA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 95 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 96 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 154
10.2.2 US 154
10.2.2.1 Rising availability of grants and funds and increasing trend of home sleep testing to drive market 154
TABLE 97 KEY SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS IN US 156
TABLE 98 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 99 US: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 100 US: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 101 US: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 102 US: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 103 US: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 104 US: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 105 US: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 106 US: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 107 US: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 108 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.2.3 CANADA 160
10.2.3.1 Increasing number of research grants and health programs to propel market 160
TABLE 109 KEY SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS IN CANADA 161
TABLE 110 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 111 CANADA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 162
TABLE 112 CANADA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 113 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 114 CANADA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 115 CANADA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 116 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 117 CANADA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 118 CANADA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 119 CANADA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 120 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10.3 EUROPE 165
10.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION 166
TABLE 121 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 122 EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 123 EUROPE: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 167
TABLE 124 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 125 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 126 EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 127 EUROPE: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 128 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 129 EUROPE: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 169
TABLE 130 EUROPE: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 131 EUROPE: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 132 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 170
10.3.2 GERMANY 170
10.3.2.1 High prevalence of obstructive sleep apnea primarily due to smoking to fuel market 170
TABLE 133 KEY SLEEP APNEA PRODUCTS BY MAJOR PLAYERS IN GERMANY 171
TABLE 134 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 135 GERMANY: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 172
TABLE 136 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 137 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 138 GERMANY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 139 GERMANY: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 140 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 141 GERMANY: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 142 GERMANY: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 143 GERMANY: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 144 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 175
10.3.3 FRANCE 175
10.3.3.1 Rising geriatric population to increase incidence of sleep apnea 175
TABLE 145 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 146 FRANCE: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 176
TABLE 147 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 148 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 149 FRANCE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 150 FRANCE: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 151 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 152 FRANCE: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 153 FRANCE: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 154 FRANCE: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 155 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 179
 
10.3.4 UK 179
10.3.4.1 Rising awareness among patients and increasing number of sleep service groups to support market 179
TABLE 156 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 157 UK: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 180
TABLE 158 UK: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 159 UK: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 160 UK: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 161 UK: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 162 UK: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 163 UK: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 182
TABLE 164 UK: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 165 UK: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 166 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 183
10.3.5 ITALY 183
10.3.5.1 Growing prevalence of sleep apnea and increasing awareness among patients regarding ill effects of disease to aid market 183
TABLE 167 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 168 ITALY: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 184
TABLE 169 ITALY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 170 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 171 ITALY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 172 ITALY: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 173 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 174 ITALY: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 187
TABLE 175 ITALY: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 176 ITALY: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 177 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 188
10.3.6 SPAIN 188
10.3.6.1 Increasing initiatives for social awareness regarding illness and treatment by regional organizations to drive market 188
TABLE 178 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 179 SPAIN: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 189
TABLE 180 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 181 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 182 SPAIN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 183 SPAIN: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 184 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 185 SPAIN: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 191
TABLE 186 SPAIN: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 187 SPAIN: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 188 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 192
10.3.7 REST OF EUROPE 192
TABLE 189 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 190 REST OF EUROPE: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 193
TABLE 191 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 192 REST OF EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 193 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 194 REST OF EUROPE: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 195 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 196 REST OF EUROPE: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 195
TABLE 197 REST OF EUROPE: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 198 REST OF EUROPE: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 199 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 196
10.4 ASIA PACIFIC 196
10.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION 196
FIGURE 31 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT 197
TABLE 200 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 197
TABLE 201 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 202 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 198
TABLE 203 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 204 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 205 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 206 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 207 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 208 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 200
TABLE 209 ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 210 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 211 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 201
10.4.2 JAPAN 201
10.4.2.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to aid market 201
TABLE 212 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 213 JAPAN: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 202
TABLE 214 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 215 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 216 JAPAN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 217 JAPAN: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 218 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 219 JAPAN: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 205
TABLE 220 JAPAN: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 221 JAPAN: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 222 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 206
10.4.3 CHINA 206
10.4.3.1 Growing adult obesity rates and expanding geriatric population to propel market 206
TABLE 223 CHINA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 224 CHINA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 207
TABLE 225 CHINA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 226 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 227 CHINA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 228 CHINA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 229 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 230 CHINA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 209
TABLE 231 CHINA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 232 CHINA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 233 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 210
10.4.4 AUSTRALIA 210
10.4.4.1 High prevalence of sleep apnea and increased number of awareness programs to drive market 210
TABLE 234 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 235 AUSTRALIA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 211
TABLE 236 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 237 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 238 AUSTRALIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 239 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 240 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 241 AUSTRALIA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 214
TABLE 242 AUSTRALIA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 243 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 244 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 215
10.4.5 REST OF ASIA PACIFIC 215
TABLE 245 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 246 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 216
TABLE 247 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 248 REST OF ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 249 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 250 REST OF ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 251 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 252 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION) 218
TABLE 253 REST OF ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 254 REST OF ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 255 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 219